RCMI Coordinating Center (RCMI CC) Header Logo

Connection

John Piletz to Receptors, Adrenergic, alpha-2

This is a "connection" page, showing publications John Piletz has written about Receptors, Adrenergic, alpha-2.
Connection Strength

2.101
  1. Chen MJ, Zhu HE, Piletz JE. Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor. Ann N Y Acad Sci. 2003 Dec; 1009:427-38.
    View in: PubMed
    Score: 0.229
  2. Piletz JE, Ordway GA, Rajkowska G, Zhu H, Klimek V, Swilley S, Duncan BJ, May W, Halaris AE. Differential expression of alpha2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects. J Psychiatr Res. 2003 Sep-Oct; 37(5):399-409.
    View in: PubMed
    Score: 0.225
  3. Zhu H, Paul IA, Stec DE, Peeler DF, Piletz JE. Non-adrenergic exploratory behavior induced by moxonidine at mildly hypotensive doses. Brain Res. 2003 Feb 21; 964(1):9-20.
    View in: PubMed
    Score: 0.217
  4. Piletz JE, Ordway GA, Zhu H, Duncan BJ, Halaris A. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain. Neuropsychopharmacology. 2000 Dec; 23(6):697-708.
    View in: PubMed
    Score: 0.186
  5. Piletz JE, Halbreich U. Imidazoline and alpha(2a)-adrenoceptor binding sites in postmenopausal women before and after estrogen replacement therapy. Biol Psychiatry. 2000 Nov 01; 48(9):932-9.
    View in: PubMed
    Score: 0.185
  6. Head GA, Chan CK, Zhu H, Piletz JE. Dissociation of the effects of intramedullary monoamine neurotoxins on the hypotensive action of moxonidine and on immunodetected imidazoline and alpha 2-receptor proteins. Ann N Y Acad Sci. 1999 Jun 21; 881:300.
    View in: PubMed
    Score: 0.168
  7. Piletz JE, Andrew M, Zhu H, Feng YZ, Rains J, Halaris A. Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age. J Psychiatr Res. 1998 Mar-Apr; 32(2):55-64.
    View in: PubMed
    Score: 0.153
  8. Piletz JE, Zhu H, Chikkala DN. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov; 279(2):694-702.
    View in: PubMed
    Score: 0.140
  9. Piletz JE, Chikkala DN, Ernsberger P. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors. J Pharmacol Exp Ther. 1995 Feb; 272(2):581-7.
    View in: PubMed
    Score: 0.124
  10. Piletz JE, Halaris A, Ernsberger PR. Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression. Crit Rev Neurobiol. 1994; 9(1):29-66.
    View in: PubMed
    Score: 0.115
  11. Piletz JE, Chikkala D, Khaitan L, Jackson K, Qu Y. Delayed desensitization of alpha 2-adrenoceptor-mediated platelet aggregation in depressed patients. Neuropsychopharmacology. 1993 Aug; 9(1):55-66.
    View in: PubMed
    Score: 0.112
  12. Zhu H, Halaris A, Piletz JE. Atypical [(3)H]clonidine binding sites in human caudate and platelets on cryostat-cut sections. Ann N Y Acad Sci. 2003 Dec; 1009:296-301.
    View in: PubMed
    Score: 0.057
  13. Zhu H, Halaris A, Piletz JE. Chronic imipramine treatment downregulates IR1-imidazoline receptors in rat brainstem. Life Sci. 1997; 61(19):1973-83.
    View in: PubMed
    Score: 0.035
  14. Piletz JE, Halaris A, Nelson J, Qu Y, Bari M. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. J Psychiatr Res. 1996 May-Jun; 30(3):147-68.
    View in: PubMed
    Score: 0.034
  15. Piletz JE, Halaris AE, Chikkala D, Qu Y. Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. J Psychiatr Res. 1996 May-Jun; 30(3):169-84.
    View in: PubMed
    Score: 0.034
  16. Piletz JE, Halaris A. Involvement of I1-imidazoline receptors in mood disorders. Ann N Y Acad Sci. 1995 Jul 12; 763:510-9.
    View in: PubMed
    Score: 0.032
  17. Piletz JE, Sletten K. Nonadrenergic imidazoline binding sites on human platelets. J Pharmacol Exp Ther. 1993 Dec; 267(3):1493-502.
    View in: PubMed
    Score: 0.029
  18. Halbreich U, Piletz JE, Carson S, Halaris A, Rojansky N. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry. 1993 Nov 15; 34(10):676-86.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support